Conditions: Hypertension
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 502
Healthy volunteers: no

Brief summary:
The general aim of this trial to determine the efficacy as measured by the percentage of patients reaching blood pressure goal at the end of the treatment period at 12 weeks. In-clinic blood pressures, home blood pressures and safety will be carefully monitored.

Detailed description:
Study Design:

Arms:
arm 1: start low dose and uptitrate to high dose on the basis of blood pressure goal

Interventions: intervention 1: telmisartan/amlodipine
Intervention descriptions: intervention 1: start low dose and uptitrate to high dose on the basis of BP goal

Protocol document: